DEFORMACIÓN DEL ACERO TRANSVERSAL

1 Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with

suppressor/cytotoxic (CD8) phenotype: Identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol. 1990; 22:569-77.

2 Alibert JLM. Description des maladies de la peau observees a l´hopital St. Lois. Barrois l`aine`et fils, Paris, 1806.

3 Anderson G, Harman BC, Hare KJ et al. Microenvironmental regulation of T cell development in the thymus. Semin Immunol. 2000; 12:457.

4 Asadullah K, Häussler-Quade A, Gellrich S et al. IL-15 and IL-16 overexpression in cutaneous T- cell lymphomas: stage dependent increase in mycosis fungoides progression. Exp Dermatol. 2000; 9:248-51.

5 Ashton-Key M, Diss TC, Du MQ et al. The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates. Am J Surg Pathol. 1997; 21:743.

6 Bertho JM, Mossalayi MD, Dalloul AH et al. Isolation of an early T-cell precursor (CFU-TL) from human bone marrow. Blood. 1990; 75:1064.

7 Blaschke V, Reich K, Middel P et al. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides. J Invest Dermatol. 1999; 113:658-63.

8 Bonner RF, Emmert-Buck M, Cole K. Laser capture microdissection: molecular analysis of tissue. Science 1997; 278(5342): 1481,1483.

9 Burg G, Dummer R, Haeffner A et al. From inflammation to neoplasia: Mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001; 137:949.

10 Cerroni L, Arzberger E, Ardigio M et al. Monoclonality of intraepidermal T Lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. J Invest Dermatol. 2000; 114:1154-7.

11 Coupland SE, Hummel M, Stein H. Lymphatisches System und Differenzierung von B und T- Lymphozyten. Der Pathologe. 2000; 21:106-12.

12 Dobbeling U, Dummer R, Laine E et al. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood. 1998; 92:252-58.

13 Dummer R, Michie S, Kell D et al. Expression of BCL-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol. 1995; 22:11-17. 14 Dummer R, Willers J, Kamarashev J et al. Pathogenesis of cutaneous lymphomas. Semin Cutan

Med Surg. 2000; 19:78-86.

15 Fitch F, Lancki D, Gajewski T. T-cell mediated immune regulation in: Fundamental Immunology, 3rd ed, New York, Raven Press, 1993; 733-56.

16 Gellrich S, Lukowsky A, Schilling T et al. Microanatomical compartments of clonal and reactive T cells in Mycosis fungoides: molecular demonstration by single cell polymerase chain reaction of T cell receptor gene rearrangements. J Invest Dermatol. 2000; 115:620-4.

17 Ghosh SK, Abrams JT, Terunuma H et al. Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood. 1994; 84:2663-71.

18 Graf A, Kaudewitz P, Simon M et al. Detection of clonality of cutaneous T-cell lymphomas using polymerase chain reaction. Pathologe. 1996; 17:446-50.

19 Greene MH, Dalager NA, Lamberg SI et al. Mycosis fungoides: Epidemiologic observations. Cancer Treat Rep. 1979; 63:597-606.

20 Hall WW, Liu CR, Schneewind O et al. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science. 1991; 253:371.

21 Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood. 1994; 84:1361. 22 Hoppe RT, Wood GS, Abel EA. Mycosis fungoides and the Sezary syndrome: pathology, staging

and treatment. Curr Probl Cancer. 1990; 14:293.

23 Jaffe ES, Chan JK, Su IJ et al. Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-11.

24 Kaudewitz P, Gummer H, Flaig MJ. Kutane Lymphome. Manual Maligne Lymphome,

25 Kaye FJ, Bunn PA Jr, Steinberg SM et al. A randomized trial comparing electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med. 1989; 321:1784.

26 Kim Y, Hoppe R. Mycosis fungoides and the Sezary syndrome. In: Cancer Medicine 4th ed, Holland J (Ed), Williams and Wilkins, Baltimore, 1997, p. 2797

27 Li Y, Hisha H, Inaba M et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: A role of stromal cells in positive selection. Exp Hematol. 2000; 28:950-60.

28 Lukowsky A, Muche JM, Sterry W et al. Detection of expanded T-cell clones in skin biopsy samples of patients with lichen slcerosus et atrophicus by T-cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol. 2000; 115:254-259.

29 Medeiros JL, Bagg A, Cossman J. Application of molecular genetics to the diagnosis of hematopoietic neoplasms. In: Neoplastic Hematopathology, Knowles DM (Ed), Williams and Wilkins, Baltimore 1992, 263-98.

30 Nickoloff BJ, Griffiths CE. Intraepidermal but not dermal T-lymphozytes are positive for a cell- cycle-associated antigen ( Ki-67) in mycosis fungoides. Am J Pathol. 1990; 136:261-6.

31 Ralfkiaer E: Immunohistochemical markers for the diagnosis of cutaneous lymphomas. Semin Diagn Pathol. 1991; 8:62-72.

32 Ralfkiaer E, Jaffe ES. Mycosis fungoides and Sézary-Syndrome. In: Jaffe ES, Harris NL, Stein H, Verdiman JW. Tumours of Haematopoetic and Lymphoid Tissues. IARC Press, Lyon 2001, 216- 20.

33 Romagnani S. Human Th-1 and Th-2 subsets: doubt no more. Immunol Today 1991; 12:256-57. 34 Saed G, Fivenson DP, Naidu Y et al. Mycosis fungoides exhibits a Th-1-type cell-mediated

cytokine profile whereas Sezary syndrome expresses a Th-2-type profile. J Invest Dermatol. 1994; 103:29-33.

35 Safai B, Myskowski PL, Dupont B et al. Association of HLA-DR5 with mycosis fungoides. J Invest Dermatol. 1983; 80:395.

36 Schiller PI, Flaig MJ, Puchta U et al. Detection of clonal T-cells in lichen planus. Arch Dermatol Res. 2000; 292:568-9.

37 Schuhmann K, Flaig MJ, Bertsch HP et al. Klonalitätsanalyse kutaner Pseudolymphome. Akt. Dermatol. 1999; 25:99-101.

38 Shapiro PE, Warburton D, Berger CL et al. Clonal chromosomal abnormalities in cutaneous T- cell lymphoma. Cancer Genet Cytogenet. 1987; 28:267-76.

39 Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol. 1994; 18:645-67.

40 Shibata DK, Arnheim N, Martin WJ. Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med. 1988; 167:225-30.

41 Smoller BR, Bishop K, Glusac E et al. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol. 1995; 19:1423.

42 Terhorst C, van Agthoven A, LeClair K et al. Biochemical studies in the human thymocyte antigens T6, T9, and T10. Cell. 1981; 23:771.

43 Vega F, Luthra R, Medeiros LJ et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 2002; 100:3369.

44 Volkenandt M, Soyer HP, Cerroni L et al. Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoides. Br J Dermatol. 1993; 128:423-8.

45 Vonderheid EC, Tan E, Sobel EL et al. Clinical implications of immunologic phenotyping in cutaneous T cell lymphoma. J Am Acad Dermatol. 1987; 17:40-52.

46 Whittemore AS, Holly EA, Lee IM et al. Mycosis fungoides in relation to environmental exposures and immun response: A case control study. J Natl Cancer Inst. 1989; 81:1560.

47 Willemze R et al. EORTC classification for primary cutaneous lymphomas. Blood 1997; 90:354- 71.

48 Wood GS, Weiss LM, Warnke RA et al. The immunopathology of cutaneous lymphomas: Immunophenotypic and immunogenotypic characteristics. Semin Dermatol. 1986; 5:334.

49 Wood GS, Hong SR, Sasaki DT et al. Leu/CD7 antigen expression by CD3+T-cells: Comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol. 1990; 22:602.

50 Wood GS, Tung RM, Haeffner A et al. Detection of clonal T-cell receptor γ gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis. J Invest Dermatol. 1994; 103:34-41.

51 Wood GS, Schaffer JM, Boni R et al. No evidence of HTLV-I proviral integration in lymphoproliferative disorders associated with cutaneous T-cell lymphoma. Am J Pathol. 1997; 150:667-73.

52 Wu K, Lund M, Bang K et al. Telomerase activity and telomere lenght in lymphocytes from patients with cutaneous T-cell lymphoma. Cancer. 1999; 86:1056-63.

53 Yazdi AS, Medeiros LJ, Puchta U et al. Improved detection of clonality in cutaneous T-cell lymphomas using laser capture microdissection. J Cutan Pathol. 2003; 30(8): 486-91.